secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0000950170-25-087888
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics stockholders elect directors, approve option exchange, ratify KPMG at 2025 annual meeting
--------------------------------------------------------------------------------

- Jennifer Buell and Ulf Wiinberg elected as Class I directors with 2,337,073 and 2,312,077 votes For, respectively.
- Option exchange proposal approved: 2,269,364 For, 97,538 Against, 1,317 Abstain, 424,803 broker non-votes.
- Ratification of KPMG LLP as auditor for FY2025: 2,773,188 For, 12,846 Against, 6,988 Abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/0000950170-25-087888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/inkt-20250618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer